EMA Urges Suspension Of European Generics Tested By Synapse
As CHMP Also Issues Positive Opinions For Four New Generics In December
At the latest CHMP meeting, the EMA revealed that it was recommending the suspension of marketing authorizations for more than 400 medicines tested by Indian CRO Synapse Labs. At the same time, the committee separately endorsed four new generics.
